University of Leicester
Browse
Lifeyeargain_BCmanuscript20190124+(003).pdf (424.69 kB)

Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated - three what-if scenarios

Download (424.69 kB)
journal contribution
posted on 2019-04-25, 11:23 authored by H Bower, TM-L Andersson, E Syrioupoulou, MJ Rutherford, M Lambe, J Ahlgren, PW Dickman, PC Lambert
Many studies have found evidence of socioeconomic differences in breast cancer survival. This study aimed to quantify the impact of removing differences in stage distribution and stage-specific relative survival between education groups in Swedish women with breast cancer. Using information from a breast cancer research database, the study population contained 62 121 women diagnosed with breast cancer in three healthcare regions of Sweden from 1992 to 2012. The loss in expectation of life and life years lost due to breast cancer were estimated using flexible parametric relative survival models by education group and age at diagnosis. The potential gain in life years and postponable deaths were calculated by applying the 1) stage distribution, 2) stage-specific relative survival, and 3) both stage distribution and stage-specific relative survival of the high education group to the low and medium education groups. For a cohort of around 3500 women diagnosed with breast cancer residing in three Swedish healthcare regions in a typical calendar year, we estimated that removing stage differences would postpone an additional 25 deaths at five years after diagnosis, and result in a gain of approximately 573 life years. Alternatively, if stage-specific breast cancer survival could be equated, approximately 692 life years could be saved and an additional 26 deaths could be postponed five years after diagnosis. Results such as these can help guide decisions on interventions intended to minimise socioeconomic differences in breast cancer outcomes.

Funding

This work was funded by the Swedish Cancer Society [CAN 2015/583] the Swedish Research Council [2017-01591] and Cancer Research UK [C14183/A18262]. We would also like to thank the Breast Cancer Quality Register steering groups in Stockholm, Uppsala-Örebro and the Northern region for allowing the data to be used for this study.

History

Citation

The Breast, 2019, 45, pp. 75-81

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences

Version

  • AM (Accepted Manuscript)

Published in

The Breast

Publisher

Elsevier for SenoNetwork, Churchill Livingstone with European Society of Breast Cancer Specialists (EUSOMA)

issn

0960-9776

Acceptance date

2019-03-09

Copyright date

2019

Publisher version

https://www.sciencedirect.com/science/article/pii/S096097761930044X

Notes

Supplementary data related to this article can be found at https://doi.org/10.1016/j.breast.2019.03.005.;The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC